Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma

Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma

<p>Abstract</p> <p>Background</p> <p>There is no standard therapeutic procedure for the hepatocellular carcinoma (HCC) in patients with poor hepatic reserve function. With the approval of newly developed chemotherapeutic agent of miriplatin, we have firstly conducted th...

Full description

Bibliographic Details
Main Authors: Kamimura Kenya, Suda Takeshi, Tamura Yasushi, Takamura Masaaki, Yokoo Takeshi, Igarashi Masato, Kawai Hirokazu, Yamagiwa Satoshi, Nomoto Minoru, Aoyagi Yutaka
Format: Article
Language:English
Published: BMC 2012-09-01
Series:BMC Gastroenterology
Subjects:
Miriplatin
Hepatocellular carcinoma
Cisplatin powder
Phase I clinical trial
Online Access:http://www.biomedcentral.com/1471-230X/12/127

Internet

http://www.biomedcentral.com/1471-230X/12/127

Similar Items